Clinical trials: Non-specific Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis, Interstitial Pneumonia
Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.
There is a rare condition causing scarring of the lungs termed interstitial lung disease. This comprises a group of conditions which can be divided into separate diseases.
- Trial name
- NCT01154998
- Where
- United Kingdom
- Volunteers
- 360 people
- Sponsor
- St George's Healthcare NHS Trust
Pulmonary Healthy Controls, Interstitial Lung Disease
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)
Current diagnostic tools used in interstitial lung disease (ILD) do not meet the challenges set by the complex pathophysiology of this heterogenous group.
- Conditions
- Pulmonary Healthy Controls, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Non-specific Interstitial Pneumonia
- Trial name
- NCT02827734
- Testing
- multiple breath washout tests, impulse oscillometry, body plethysmography
- Where
- Germany
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Universitätsmedizin Mannheim
Idiopathic Pulmonary Fibrosis, Idiopathic Non-specific Interstitial Pneumonitis
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring condition of the lungs the cause of which is unknown.There are currently no effective treatments for IPF and the condition tends to cause progressive disability and…
- Trial name
- PROFILE (NCT01110694)
- Where
- United Kingdom
- Volunteers
- 230 people
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
Lung Disease, Interstitial
Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases
The purpose of the study is to evaluate the efficacy on lung function 6 months after one course of rituximab (2 infusions) and mycophénolate mofétil (MMF) treatment compared to one course of placebo and 6 months of MMF treatment…
- Trial name
- EvER-ILD (NCT02990286)
- Testing
- Rituximab, Mycophenolate Mofetil
- Where
- 5 sites in France
- Volunteers
- 122 people
- Sponsor
- University Hospital, Tours